OA10195A - Carbazole derivatives with 17 20-lyase-inhibiting activity - Google Patents
Carbazole derivatives with 17 20-lyase-inhibiting activity Download PDFInfo
- Publication number
- OA10195A OA10195A OA60742A OA60742A OA10195A OA 10195 A OA10195 A OA 10195A OA 60742 A OA60742 A OA 60742A OA 60742 A OA60742 A OA 60742A OA 10195 A OA10195 A OA 10195A
- Authority
- OA
- OAPI
- Prior art keywords
- compound
- formula
- group
- daims
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10195A true OA10195A (en) | 1996-12-18 |
Family
ID=10736007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60742A OA10195A (en) | 1993-05-21 | 1995-11-17 | Carbazole derivatives with 17 20-lyase-inhibiting activity |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0699196A1 (online.php) |
| JP (1) | JPH08510455A (online.php) |
| CN (1) | CN1126473A (online.php) |
| AU (1) | AU6928794A (online.php) |
| BG (1) | BG100154A (online.php) |
| CA (1) | CA2162921A1 (online.php) |
| CZ (1) | CZ305195A3 (online.php) |
| FI (1) | FI955587A7 (online.php) |
| GB (1) | GB9310635D0 (online.php) |
| HU (1) | HUT73790A (online.php) |
| IL (1) | IL109703A0 (online.php) |
| NO (1) | NO954681L (online.php) |
| OA (1) | OA10195A (online.php) |
| PE (1) | PE31195A1 (online.php) |
| PL (1) | PL311702A1 (online.php) |
| SK (1) | SK142495A3 (online.php) |
| TW (1) | TW279866B (online.php) |
| WO (1) | WO1994027989A1 (online.php) |
| ZA (1) | ZA943494B (online.php) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1131944A (zh) * | 1993-09-30 | 1996-09-25 | 山之内制药株式会社 | 唑类衍生物和它的药物组合物 |
| WO1996014090A1 (en) * | 1994-11-07 | 1996-05-17 | Janssen Pharmaceutica N.V. | Compositions comprising carbazoles and cyclodextrins |
| PL322028A1 (en) * | 1995-03-01 | 1998-01-05 | Yamanouchi Pharma Co Ltd | Derivatives of imidazoles and pharmaceutic composition containing them |
| EP0974584B1 (en) * | 1997-02-21 | 2003-01-15 | Takeda Chemical Industries, Ltd. | Fused ring compounds, process for producing the same and use thereof |
| EP1334106B1 (en) | 2000-11-17 | 2006-05-24 | Takeda Pharmaceutical Company Limited | Imidazole derivatives, production method thereof and use thereof |
| ATE502030T1 (de) | 2000-11-20 | 2011-04-15 | Takeda Pharmaceutical | Imidazolderivate, verfahren zu deren herstellung und deren verwendung |
| WO2002046186A1 (en) | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| MX2007015905A (es) * | 2005-06-24 | 2008-03-06 | Lilly Co Eli | Derivados de tetrahidrocarbazol utiles como moduladores de receptor de androgeno (sarm). |
| GB0525323D0 (en) | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
| US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
| CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
| MA33451B1 (fr) | 2009-06-26 | 2012-07-03 | Novartis Ag | Dérivés d'imidazolidin-2-one 1,3-disubstitués en tant qu'inhibiteurs de cyp 17 |
| CA2788907A1 (en) * | 2010-02-04 | 2011-08-11 | Radius Health, Inc. | Selective androgen receptor modulators |
| PT2568806T (pt) | 2010-05-12 | 2016-08-05 | Radius Health Inc | Regimes terapêuticos |
| US9132105B2 (en) | 2010-08-04 | 2015-09-15 | Pellficure Pharmaceuticals, Inc. | Treatment of prostate carcinoma |
| JP2013537210A (ja) | 2010-09-16 | 2013-09-30 | ノバルティス アーゲー | １７α−ヒドロキシラーゼ／Ｃ１７，２０−リアーゼ阻害剤 |
| ES2550319T3 (es) | 2010-09-28 | 2015-11-06 | Radius Health, Inc | Moduladores selectivos del receptor de andrógenos |
| EA023064B1 (ru) | 2011-04-28 | 2016-04-29 | Новартис Аг | ИНГИБИТОРЫ 17α-ГИДРОКСИЛАЗЫ/C-ЛИАЗЫ |
| US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| AU2014241816B9 (en) | 2013-03-14 | 2019-02-14 | Pellficure Pharmaceuticals Inc. | Novel therapy for prostate carcinoma |
| RS67458B1 (sr) | 2014-03-28 | 2025-12-31 | Univ Duke | Lečenje kancera dojke pozitivnog na receptor estrogena upotrebom selektivnih modulatora receptora estrogena |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| CA2960750A1 (en) | 2014-09-12 | 2016-03-17 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| RS63311B1 (sr) | 2016-06-22 | 2022-07-29 | Ellipses Pharma Ltd | Ar+ metode lečenja raka dojke |
| WO2018080933A1 (en) | 2016-10-24 | 2018-05-03 | Pellficure Pharmaceuticals Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
| KR102881465B1 (ko) | 2017-01-05 | 2025-11-04 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 EP EP94917647A patent/EP0699196A1/en not_active Withdrawn
- 1994-05-19 CA CA002162921A patent/CA2162921A1/en not_active Abandoned
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/en not_active Ceased
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 FI FI955587A patent/FI955587A7/fi not_active Application Discontinuation
- 1995-11-20 NO NO954681A patent/NO954681L/no unknown
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0699196A1 (en) | 1996-03-06 |
| JPH08510455A (ja) | 1996-11-05 |
| NO954681D0 (no) | 1995-11-20 |
| IL109703A0 (en) | 1994-08-26 |
| PE31195A1 (es) | 1995-10-18 |
| CA2162921A1 (en) | 1994-12-08 |
| SK142495A3 (en) | 1996-06-05 |
| CN1126473A (zh) | 1996-07-10 |
| FI955587A0 (fi) | 1995-11-20 |
| PL311702A1 (en) | 1996-03-04 |
| CZ305195A3 (en) | 1996-06-12 |
| WO1994027989A1 (en) | 1994-12-08 |
| FI955587A7 (fi) | 1995-11-20 |
| HU9503321D0 (en) | 1996-01-29 |
| BG100154A (en) | 1996-07-31 |
| GB9310635D0 (en) | 1993-07-07 |
| TW279866B (online.php) | 1996-07-01 |
| HUT73790A (en) | 1996-09-30 |
| ZA943494B (en) | 1995-01-23 |
| AU6928794A (en) | 1994-12-20 |
| NO954681L (no) | 1995-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0699196A1 (en) | Carbazole derivatives with 17,20-lyase-inhibiting activity | |
| EP1373224B1 (en) | New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors | |
| IE904146A1 (en) | Indole Derivatives | |
| AU2014300894A1 (en) | Therapeutically active 17-nitrogen substituted estratrienthiazole derivatives as inhibitors of 17.beta.-hydroxysteroid dehydrogenase | |
| US6689798B2 (en) | Benzofuran derivatives | |
| SU1549485A3 (ru) | Способ получени производных 6-метиленандроста-1,4-диен-3,17-диона | |
| CA2214744C (en) | 3-(bis-substituted phenylmethylene)oxindole derivatives | |
| CA2553345C (en) | Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 | |
| US5578630A (en) | Heterocyclic compounds which inhibit aromatase | |
| KR19980702319A (ko) | 이미다졸 유도체 및 이의 의약 조성물 | |
| Branchaud | Studies on the development of the tritylsulfenyl group as a nitrogen protecting group and application in a synthesis of. delta.-coniceine | |
| EP0240263B1 (en) | Indenopyrimidine derivatives | |
| DK149469B (da) | 3,5-disubstitueret 1h-1,2,4-triazolderivat til anvendelse som antireproduktivt middel | |
| HU229135B1 (en) | Benzofurane derivatives | |
| KR102406248B1 (ko) | Hsp90 억제제로서의 1,2,3-트리아졸 유도체 화합물 | |
| US5726196A (en) | Aromatase-inhibiting composition containing azole derivative | |
| JPS6258354B2 (online.php) | ||
| HU191597B (en) | Process for producing of 2-/2-indalin/-imadazoline preparates and medical preparates consisting of such substances | |
| HUT59107A (en) | Process for producing new 4(5)-imidazole derivatives having aromatase inhibiting activity and pharmaceutical compositions comprising same as active ingredient | |
| US4064177A (en) | 3-Alkoxy-D-homo-C-nor-13α, 14α-gona-1,3,5,(10),6,8-pentaen-17-one and derivatives thereof | |
| JPS6256471A (ja) | 含窒素四環式化合物 | |
| US4055649A (en) | 4-Alkyl-2,6-di-(secondary or tertiary alkyl)amino-3-formylpyridines pharmaceutical compositions thereof and their use in the treatment of obesity and diabetes | |
| JP2002030063A (ja) | スルファメート化合物の製造方法 | |
| JPS6172763A (ja) | プレニルベンズイミダゾ−ル誘導体および抗潰瘍剤 | |
| GB2034710A (en) | 1H-1,2,4-triazoles |